Encompass Health Corporation (EHC) Tops Q1 EPS by 1c; Cannot Accurately Estimate Financial Results

Encompass Health Corporation (NYSE: EHC) reported Q1 EPS of $0.87, $0.01 better than the analyst estimate of $0.86. Revenue for the quarter came in at $1.18 billion versus the consensus estimate of $1.2 billion.

"Through February, our operating performance was strong in both business segments," said President and Chief Executive Officer of Encompass Health Mark Tarr. "Beginning in March, we experienced lower volumes and higher operating expenses related to the COVID-19 pandemic. While we expect these lower volumes to continue in the near term, we view them as temporary and remain confident in the intermediate and long-term growth prospects for our Company based on the increasing demands for the services we provide to an aging population."

GUIDANCE:

Given the rapidly changing operating conditions related to the COVID-19 pandemic, the Company cannot accurately estimate the effects it may have on its full-year 2020 financial results. As a result, the Company withdrew its 2020 guidance and five-year growth targets in a Current Report on Form 8-K filed on April 16, 2020.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• This healthcare stock is on TD Cowen's Best Ideas list
• Goldman "broadly" raises estimates for LTL and truckload stocks